Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00386308 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety Study of XP12B in Women With Menorrhagia
A Phase 3 study of Menorrhagia and Heavy Menstrual Bleeding, sponsored by Ferring Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 196
- Enrollment target
- 20
- Study locations
NCT00386308: Completed Phase 3 study of Menorrhagia and Heavy Menstrual Bleeding, sponsored by Ferring Pharmaceuticals.
NCT00386308 is a Phase 3 study of Menorrhagia and Heavy Menstrual Bleeding that has completed, run by Ferring Pharmaceuticals. The registered enrollment target is 196 participants, roughly in line with the 209-participant average among 10 other Menorrhagia trials with a reported enrollment target. The trial reports 20 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00386308, a Phase 3 study of Menorrhagia and Heavy Menstrual Bleeding, has completed, sponsored by Ferring Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 196 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to determine whether XP12B is effective and safe in the treatment of women with heavy menstrual bleeding associated with menorrhagia.
Primary Outcome
reduction of menstrual blood loss in mL
Conditions Studied
Interventions
- DRUG Tranexamic acid tablets
- DRUG Placebo tablets
Study Locations (20)
Georgia
- Investigative Site - Atlanta
- Investigative Site - Atlanta
- Investigative Site - Decatur
- Investigative Site - Savannah
California
- Investigative Site - Carmichael
- Investigative Site - San Diego
- Investigative Site - Upland
Florida
- Investigative Site - Inverness
- Investigative Site - Miami
- Investigative Site - Miami
Arizona
- Investigative Site - Tucson
- Investigative Site - Tucson
Colorado
- Investigative Site - Denver
- Investigative Site - Lakewood
Connecticut
- Investigative Site - Groton
- Investigative Site - West Hartford
Louisiana
- Investigative Site - Amite
- Investigative Site - Baton Rouge
Arkansas
- Investigative Site - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2006-10 |
| Est. Completion | 2008-05 |
| Phase | Phase 3 |
What the finished NCT00386308 record still lists
NCT00386308 is an interventional study that assigns participants to a tested intervention. The registered 196 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 209-participant average among 10 other Menorrhagia trials with a reported enrollment target.
The record links to 2 conditions, with Menorrhagia appearing as the primary indexed condition, and to 2 interventions - of which Tranexamic acid tablets is the first listed.
NCT00386308 names 20 study sites across 9 states, led by Georgia, California, Florida.
Frequently Asked Questions
What is clinical trial NCT00386308 about?
NCT00386308 is a clinical study titled "Efficacy and Safety Study of XP12B in Women With Menorrhagia". The purpose of this study is to determine whether XP12B is effective and safe in the treatment of women with heavy menstrual bleeding associated with menorrhagia.
What is the current status of trial NCT00386308?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 196 participants. The study started on 2006-10. Estimated completion is 2008-05.
What conditions does trial NCT00386308 study?
This clinical trial studies the following conditions: Menorrhagia, Heavy Menstrual Bleeding.
What interventions are being tested in trial NCT00386308?
The interventions under investigation include: Tranexamic acid tablets (DRUG), Placebo tablets (DRUG).
Who is sponsoring clinical trial NCT00386308?
This trial is sponsored by Ferring Pharmaceuticals, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00386308 being conducted?
This trial has 20 study locations across Arizona, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Menorrhagia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00386308's enrollment target sits among peer trials
196 5th of 10 higher than 6 of 10 other Menorrhagia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Menorrhagia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Tranexamic Acid (XP12B) in Women With Heavy Menstrual Bleeding
COMPLETED · Phase 3
-
Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)
COMPLETED · Phase 3
-
A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device
RECRUITING
-
Surgical Success After Laparoscopic vs Abdominal Hysterectomy
COMPLETED · NA
-
Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation
COMPLETED
-
Minerva Pivotal Study to Evaluate Safety and Efficacy of the Aurora Endometrial Ablation System Compared to Hysteroscopic Rollerball Ablation
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02822768 · 196 participants · NA
Packing Versus no Packing for Cutaneous Abscess
- NCT04250259 · 196 participants · Phase 2
SAMe Trial for Patients With Alcoholic Cirrhosis
- NCT05142592 · 196 participants · Phase 1
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
- NCT05317832 · 196 participants · Phase 2
Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia